Persistent Cervical Cancer
3 clinical trials · Condition
◉ Watch Persistent Cervical Cancer
| Record | Firm | Date |
|---|---|---|
| First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer (NCT04974944) | Sun Yat-Sen University Cancer Center | 2021-07-30 |
| Cabozantinib Plus Pembrolizumab for Recurrent, Persistent and/or Metastatic Cervical Cancer (NCT04230954) | University of South Alabama | 2020-04-16 |
Track Persistent Cervical Cancer automatically
Every clearance here is in the API, with alerts when new ones post.